UCLA researchers and collaborators led by Dean Ho, a professor at the UCLA School of Dentistry and co-director of the school's Jane and Jerry Weintraub Center for Reconstructive Biotechnology, have developed a potentially more effective treatment for "triple-negative" breast cancer that uses nanoscale, diamond-like particles called nanodiamonds. Read more here.
Study mentioned: Moore L, et al. Diamond-Lipid Hybrids Enhance Chemotherapeutic Tolerance and Mediate Tumor Regression. Adv Mater. 2013 Apr 15. [Epub ahead of print] PMID: 23584895
No comments:
Post a Comment